Weaponized Safety: How the FDA Is Killing mRNA
The FDA's refusal to review Moderna's flu vaccine isn't about safety. It is about a retroactive change in math that protects incumbents and drives innovation offshore.
2 articles
The FDA's refusal to review Moderna's flu vaccine isn't about safety. It is about a retroactive change in math that protects incumbents and drives innovation offshore.
Federal health officials have released a comprehensive 'OneHHS' plan, signaling a unified push for agentic AI in healthcare. Here's what the strategy means for the future of medicine.